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CORRESPONDENCE
Cigar Smoking and Cancers of
the Upper Digestive Tract
Cigar smoking has been rising over
the past few years, mainly in North
America, but its health consequences
have been quantified only recently (1,2).
With reference to lung cancer, in several
case–control studies conducted in the
1960s and 1970s, summarized by Hig-
gins et al. (3), the odds ratios (ORs) for
cigar smokers ranged between 2 and 5.
A cohort investigation, based on a
sample of 25 000 Swedish men (4), gave
a relative risk (RR) of lung cancer of 7.6
for current cigar smokers as compared
with never smokers.
The difference between cigarette and
cigar smoking is generally considered
most marked with respect to lung cancer
and less marked with respect to cancers
of the mouth, pharynx, and esophagus
(2,4). Much less information, however,
is available on these cancer sites because
most studies combined cigar with ciga-
rette or pipe smokers. The Swedish co-
hort study (3) gave an RR for cigar
smokers of 0.6 for oral cavity and pha-
ryngeal cancers and of 6.5 for esopha-
geal cancer on the basis, however, of
only one and two cases. The Cancer Pre-
vention Study-I (CPS-I) (2), on the basis
of 25 deaths from oral and pharyngeal
cancers, gave RRs of 7.9 for ever cigar
smokers and of 15.9 for heavy (>5 per
day) cigar smokers. Corresponding fig-
ures for esophageal cancer, on the basis of
19 deaths, were 3.6 for ever cigar smokers
and 5.2 for heavy cigar smokers (2).
We have, therefore, considered the
risk of cancers of the upper digestive
tract in individuals who had smoked
only cigars as compared with lifelong
nonsmokers; we used data from a case–
control study conducted in Italy and
Switzerland (5,6). Briefly, between
1984 and 1997, data were collected by
trained interviewers on 1090 men with
incident, histologically confirmed can-
cers of the oral cavity and pharynx and
343 men with such cancers of the
esophagus who were admitted to a net-
work of hospitals in the greater Milan
area, the northern Italian province of
Pordenone, and the Swiss Canton of
Vaud. Control subjects were 3070 men
admitted to the same network of hospi-
tals for acute, non-neoplastic conditions
that were unrelated to alcohol or tobacco
consumption. Information on smoking
habits included smoking status, type of
product smoked, quantity of tobacco
smoked, and duration of being a smoker.
Ever cigarette and pipe smokers were
excluded from this analysis, leaving a to-
tal of 59 case patients (36 with oral and
pharyngeal cancers and 23 with esopha-
geal cancer) and 801 control subjects.
Nine (15.3%) of the 59 case patients
and 13 (1.6%) of the 801 control sub-
jects were ever cigar smokers. The cor-
responding OR obtained by uncondi-
tional multiple logistic regression—after
allowance for study center, age, alcohol
consumption, and education—was 6.8
(95% confidence interval [CI] 4 2.5–
18.5). The ORs were 8.9 (95% CI 4
2.1–36.9) for smokers of more than 3
cigars per day and 14.9 (95% CI 4 4.0–
55.9) for current cigar smokers (Table
1). The ORs for ever cigar smokers were
9.0 (95% CI 4 2.7–30.0) for oral and
pharyngeal cancers and 4.1 (95% CI 4
0.7–23.0) for esophageal cancer.
The present data, therefore, provide
quantitative evidence that cigar smoking
is strongly related to cancers of the up-
per digestive tract, even in men who
have never smoked cigarettes or pipes.
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Table 1. Distribution by cigar-use status of 59 male case patients with cancers of the oral cavity,
pharynx, and esophagus and 801 male control subjects who never smoked cigarettes or pipes with
corresponding odds ratios*—data collected in Italy and Switzerland, 1984–1997
Case patients Control subjects
OR (95% CI)†No. % No. %
Cigar smoking
Never 50 84.7 788 98.4 1‡
Ever 9 15.3 13 1.6 6.8 (2.5–18.5)
>3 cigars per day 4 6.8 5 0.6 8.9 (2.1–36.9)
Current only 7 11.9 5 0.6 14.9 (4.0–55.9)
*Derived from unconditional multiple logistic regression equations, including terms for study center,
age, alcohol consumption, and education. The assumptions of multiple logistic regression analysis were
met.
†OR 4 odds ratio; CI 4 confidence interval.
‡Reference category.
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